Start your scheming now for SUNDAY'S WRITE-A-THON! • May 2, 2021Theme: Arts and Recreation!

Search results

Jump to: navigation, search

Page title matches

  • #REDIRECT [[Bioequivalence]]
    28 B (2 words) - 04:30, 2 February 2009
  • In [[medicine]] and [[pharmacology]], '''bioequivalence''', or '''therapeutic equivalency''', is "the relative equivalency in t ==Pharmaceutical bioequivalence==
    5 KB (657 words) - 04:50, 13 July 2010
  • 127 B (16 words) - 09:51, 7 September 2009
  • Auto-populated based on [[Special:WhatLinksHere/Bioequivalence]]. Needs checking by a human.
    489 B (62 words) - 16:22, 11 January 2010

Page text matches

  • #REDIRECT [[Bioequivalence]]
    28 B (2 words) - 04:30, 2 February 2009
  • {{r|Bioequivalence}}
    274 B (29 words) - 19:30, 3 December 2008
  • '''Bioequivalence''' covers the case where the initial distribution of different drug pre ...ribution = Subcapter D, Drugs for Human Use, Part 320: Bioavailability and Bioequivalence requirements
    1 KB (140 words) - 06:56, 11 June 2010
  • {{r|Bioequivalence}}
    592 B (75 words) - 21:48, 11 January 2010
  • In [[medicine]] and [[pharmacology]], '''bioequivalence''', or '''therapeutic equivalency''', is "the relative equivalency in t ==Pharmaceutical bioequivalence==
    5 KB (657 words) - 04:50, 13 July 2010
  • "'B' drugs have not been demonstrated to be bioequivalent by an ''in vivo'' test."<ref name="pmid12405134">{{cite journal| author= <td width="25%">Products in conventional dosage forms not presenting bioequivalence problems.</td>
    14 KB (1,979 words) - 09:31, 13 July 2010
  • ...example where pharmagological bioequivalence does not predict therapeutic bioequivalence.<ref name="pmid20547818">{{cite journal| author=Vesga O, Agudelo M, Sal ...er existing brand name drugs to allow them to manufacture [[bioequivalence|bioequivalent]] versions.
    18 KB (2,543 words) - 14:35, 31 March 2011
  • {{r|Bioequivalence}}
    1 KB (150 words) - 00:29, 12 January 2010
  • ...example where pharmagological bioequivalence does not predict therapeutic bioequivalence.<ref name="pmid20547818">{{cite journal| author=Vesga O, Agudelo M, Sal
    12 KB (1,633 words) - 17:06, 27 November 2010
  • {{r|Bioequivalence}}
    3 KB (369 words) - 22:37, 10 September 2012
  • ...g]]s. The [http://www.fda.gov/cder/ob/ Orange Book] contains all approved bioequivalent generic drugs. The OGD also maintains [http://www.fda.gov/cder/ogd/Autho ...ical to that of the previously approved drug, that its formulation shows [[bioequivalence]] to the previously approved formulation in small human trials, and tha
    40 KB (5,751 words) - 09:07, 19 September 2013
  • {{r|Bioequivalence}}
    4 KB (505 words) - 21:36, 11 January 2010